Saudi Pharmaceutical Industries and Medical Appliances Corporation
2070XSAUSaudi Exchange·Healthcare
SAR 29.70
▼︎ 0.13%(-0.04)
Closed
Data as of May 14, 2026Data as of 14 May 2026
Open
SAR 29.74
High
SAR 30.00
Low
SAR 29.50
Volume
408.5K
52W High
SAR 33.12
52W Low
SAR 21.76
1W
-2.50%
1M
-8.84%
3M
+9.59%
6M
+13.53%
YTD
+13.53%
1Y
+4.65%
Mīzān Analysis
25/60
Mixed signals — review dimensions carefully
2070Sector
Market Cap
3.5B SAR
P/E
27.4
Revenue Growth
1.8%
Div Yield
2.02%
Rewards
No standout positive signals at current scores.
Risk Analysis
No significant risk flags at current scores.
Scores computed 16 May 2026
Fundamentals
Market Cap
P/E Ratio
P/B Ratio
EPS
EPS Growth
Revenue
Revenue Growth
Net Income
Profit Margin
Debt / Assets
Dividend Yield
Dividend Per Share
Shares Outstanding
Reporting Period: 2024-12-31Updated yesterday
Mizān Summary
News
Sector News10Industry & macro context
UAE Business: MedLab launches new surgical training hub at Dubai Science Park
Gulf Daily News· 3 days agoNeutralEconomy
UAE launches global plan to reach 42 million people, eradicate river blindness by 2030
Economy Middle East· 6 days agoNeutral
UAE Business: PureHealth surpasses $1.72bn in local procurement spend
Gulf Daily News· 10 days agoEconomy
Bahrain SWF Mumtalakat, SandboxAQ to boost Bahrain’s biotech sector
MSN· 16 days agoNeutralEconomy
Abu Dhabi’s PureHealth Q1 2026 revenue rises 10 percent to $2 billion on global expansion
Economy Middle East· 16 days agoNeutral
Omani delegation visits China to explore high tech pharmaceutical and medical ventures
Times of Oman· 19 days agoNeutralEconomy
Memo to enhance training, employment in pharmaceutical industry inked
وكالة الانباء الاردنية· 27 days agoNeutralEconomy
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
CNBC Business· about 1 month agoNeutralMarket Movers
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
CNBC Business· about 1 month agoPositiveMarket Movers
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides
MarketWatch Top Stories· about 1 month agoPositiveEconomy
Events
No upcoming corporate events